Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Sell
28
GRCE Quote, Financials, Valuation and Earnings
Last price:
$2.37
Seasonality move
:
-1.52%
Day range:
$2.16 - $2.29
52-week range:
$2.07 - $4.97
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.60x
Volume:
33.4K
Avg. volume:
91.3K
1-year change:
-32.25%
Market cap:
$31.4M
Revenue:
--
EPS (TTM):
-$1.54
Earnings Data
Next earnings date for GRCE
Jun 20
2025
Most recent earnings per share
-$0.36
Missed by $0.04
(Feb 13/2025)
Consensus Estimate
-$0.32
(Feb 13/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
GRCE Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/20/2025 | Q1 | -- | -- | -- | -$0.24 | -- |
| 02/13/2025 | Q4 | -- | -- | -$0.36 | -$0.32 | -$0.04 |
| 11/13/2024 | Q3 | -- | -- | -$0.30 | -$0.36 | $0.06 |
| 08/09/2024 | Q2 | -- | -- | -$0.24 | -$0.26 | $0.02 |
| 03/31/2024 | Q1 | -- | -- | -$0.64 | -$0.35 | -$0.29 |
| 12/31/2023 | Q4 | -- | -- | -$0.32 | -$0.23 | -$0.09 |
| 09/30/2023 | Q3 | -- | -- | -$0.43 | -$0.26 | -$0.17 |
| 06/30/2023 | Q2 | -- | -- | -$0.54 | -$0.28 | -$0.26 |
| 03/31/2023 | Q1 | -- | -- | -$3.91 | -$0.83 | -$3.08 |
| 12/31/2022 | Q4 | -- | -- | -$0.52 | -$0.75 | $0.23 |
| 09/30/2022 | Q3 | -- | -- | -$0.66 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$0.61 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$0.53 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$0.54 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | $0.18 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$0.72 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$1.30 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$1.56 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$3.12 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$2.40 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | $10.08 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$6.72 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$12.00 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$5.28 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$8.61 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$2.47 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$23.03 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$8.39 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$11.36 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$15.27 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$11.99 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$7.01 | -- | -- |
| 11/30/2016 | Q4 | -- | -- | -$7.86 | -- | -- |
| 08/31/2016 | Q3 | -- | -- | -$8.07 | -- | -- |
| 05/31/2016 | Q2 | -- | -- | -$10.67 | -- | -- |
| 02/29/2016 | Q1 | -- | -- | -$6.18 | -- | -- |
| 11/30/2015 | Q4 | -- | -- | -$7.54 | -- | -- |
| 08/31/2015 | Q3 | -- | -- | -$4.35 | -- | -- |
| 05/31/2015 | Q2 | -- | -- | -$3.48 | -- | -- |
Grace Therapeutics Earnings Questions
-
How Much did Grace Therapeutics Generate in Revenue Last Quarter?
Grace Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Grace Therapeutics Beat Earnings Last Quarter?
Grace Therapeutics announced earnings per share of -$0.36 which represents a miss of analyst forecast a -$0.32 per share.
-
Is Grace Therapeutics Profitable?
Grace Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Grace Therapeutics EPS Next Year?
Grace Therapeutics's earnings are forecast to decrease from -$1.73 per share to -$1.44 per share next year representing a decrease of -28.63%.
-
When is Grace Therapeutics's Earnings Date?
Grace Therapeutics's next earnings date is June 20, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
